Nextage Therapeutics Ltd (TLV:NXTG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 81.00
-2.40 (-2.88%)
May 13, 2025, 5:13 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 66.32 million as of May 13, 2025. Its market cap has increased by 402.86% in one year.
Market Cap
66.32M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
81.00
Market Cap Chart
Since August 31, 2020, Nextage Therapeutics's market cap has decreased from 110.42M to 66.32M, a decrease of -39.94%. That is a compound annual growth rate of -10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 64.42M | 143.52% |
| Dec 31, 2024 | 26.45M | 168.30% |
| Dec 31, 2023 | 9.86M | -39.56% |
| Dec 29, 2022 | 16.31M | -71.75% |
| Dec 30, 2021 | 57.75M | -26.29% |
| Dec 31, 2020 | 78.35M | -29.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 774.95M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |